RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2015 October; 6(4): e0043. ISSN: 2076-9172
Published online 2015 October 26. doi: 10.5041/RMMJ.10221

Correction for the article “Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?” by Moussa B. H. Youdim

Copyright: © 2015 Youdim.

This is an open-access article. All its content, except where otherwise noted, is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

CORRECTION

In the following paper: Youdim MBH. Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson’s and Alzheimer’s disorders? Rambam Maimonides Med J 2010;1(2):e0011. doi:10.5041/RMMJ.10011, it was noted that the Acknowledgement regarding the source of the text was not published. The following Acknowledgement has been added:

Acknowledgement: This article is reprinted with slight modifications from Youdim MBH. Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Diseases as Disease Modifying Agents. Exp Neurobiol. 2010;19(1):1–14, under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/).

The HTML and PDF versions of the paper have been corrected in the RMMJ.org.il archives.

Published: August 31, 2015

Footnotes

Conflict of interest: No potential conflict of interest relevant to this article was reported.